Patient Education Is a Critical Role for the Nurse Navigator and Advanced Care Practitioner

Video Library —July 1, 2021
Megan Price, MSN, APRN, FNP-C
Baylor Charles A. Sammons Cancer Center
Dallas, TX
Virginia Seery, CRNP, MSN
Beth Israel Deaconess Medical Center, Harvard Medical School Teaching Hospital, Boston, MA
Laura Wood, RN, MSN, OCN
Cleveland Clinic Taussig Cancer Center
Cleveland, OH
There are currently many online and print resources that you can use to help fulfill your patients’ educational needs. However, nurse navigators and advanced care practitioners can also call upon their training and experience to help patients better understand what they are about to undergo. Please join Laura Wood, RN, MSN, OCN; Virginia Seery, MSN, RN, ANP-BC, AOCNP; and Megan Price, MSN, APRN, FNP-C, as they discuss their best practices for helping patients understand their diagnosis, treatment options, and potential adverse events.
Related Articles
Overview of Current Imaging Modalities in Prostate Cancer
Neal Shore, MD, FACS
|
Video Library
Dr Neal Shore introduces the current global landscape of various imaging modalities for prostate cancer, including a new prostate-specific membrane antigen (PSMA)-targeted PET/CT agent, PYLARIFY® (piflufolastat F 18).
Quality of Life with Combination Therapy in Advanced Renal-Cell Cancer
Laura Wood, RN, MSN, OCN, Megan Price, MSN, APRN, FNP-C, Virginia Seery, CRNP, MSN
|
Video Library
Laura Wood, RN, MSN, OCN; Megan Price, MSN, APRN, FNP-C; and Virginia Seery, MSN, RN, ANP-BC, AOCNP, discuss strategies for addressing patients’ concerns about how combination therapy may impact their activities of daily living and quality of life.
The Impact of Real-World Data on Efficacy and Safety of Agents for Advanced Renal-Cell Cancer
Laura Wood, RN, MSN, OCN, Megan Price, MSN, APRN, FNP-C, Virginia Seery, CRNP, MSN
|
Video Library
The last 10 to 15 years has seen important advances in the management of advanced renal-cell cancer. Laura Wood, RN, MSN, OCN; Megan Price, MSN, APRN, FNP-C; and Virginia Seery, MSN, RN, ANP-BC, AOCNP, discuss how real-world efficacy and safety data influence the conversations they have with their patients with advanced renal-cell carcinoma regarding treatment options.
Last modified: July 1, 2021

Subscribe to the Journal of Oncology Navigation & Survivorship®

To sign up for our print publication or e-newsletter, please enter your contact information below.

  • First Name *
    Last Name *
     
     
    Profession or Role
    Primary Specialty or Disease State
    Country
  • Please enter your mailing address.

    Address
     
    Address Line 2
    City
     
    State
    Zip Code